Investors
General description
Share capital: PLN 344,094.70 (fully paid up)
Due to the entry into force of the Act of 30 August 2019 amending the Commercial Companies Code Act and certain other laws (Journal of Laws of 2019, item 1798), the company has dematerialised the shares. From 1 March 2021, the Company’s Shareholders’ Register was kept by BDM Brokerage House, while as of 14 January 2022, the Company’s Shareholders’ Register has been kept by Navigator Brokerage House.
Documents to download
2025
Calls to submit shares in the company
No documents to download. Select a different year from the drop-down list.Shareholders' meetings
No documents to download. Select a different year from the drop-down list.Financial statements, Management Reports and Independent Statutory Auditor's Reports
No documents to download. Select a different year from the drop-down list.2023-12-31 Financial statement for 2023(pdf, 1 MB)
2023-12-31 Sprawozdanie Zarządu za rok 2023(pdf, 1 MB)
2022-12-31 Financial statement for 2022(pdf, 1 MB)
2021-12-31 Financial statement for 2021(pdf, 1 MB)
2020-12-31 Financial statement for 2020(pdf, 1 MB)
2019-12-31 Financial statement for 2019(pdf, 1 MB)
2018-12-31 Financial statement for 2018(pdf, 2 MB)
Articles of association and other documents
No documents to download. Select a different year from the drop-down list.Articles of association(pdf, 225 KB)
Regulamin Rejestru akcjonariuszy(pdf, 390 KB)
Breakthrough in regenerative medicine
Medical Inventi researches, creates, develops and commercialises innovative medical product solutions focusing on improving patients’ quality of life.
We are the exclusive owner of the know-how, technology and patents relating to FlexiOss®.
